ACT Lung Health Intervention: Phase Two

NANot yet recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Smoking CessationSmoking BehaviorsSmoking, TobaccoSmoking, CigaretteSmoking (Tobacco) Addiction
Interventions
BEHAVIORAL

ACT Lung Health Intervention

An Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform.

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT06945120 - ACT Lung Health Intervention: Phase Two | Biotech Hunter | Biotech Hunter